The State Food and Drug Administration (SFDA) issued the No.80 Drug Administrative Protection Announcement on December 12, 2005, declaring the obtainment of drug administrative protection for Fresenius Kabi Pharmaceutical Co Ltd's Structolipid (purified structured triglyceride).